These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6162036)

  • 21. Correlation of the cell surface antigens with stage and grade in cancer of the bladder.
    Emmott RC; Javadpour N; Bergman SM; Soares T
    J Urol; 1979 Jan; 121(1):37-9. PubMed ID: 759641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1649-62. PubMed ID: 3825814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cell surface antigen A, B or O(H) as an indicator of malignant potential in stage A bladder carcinoma: preliminary report.
    Bergman S; Javadpour N
    J Urol; 1978 Jan; 119(1):49-51. PubMed ID: 621814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant glandular lesions and glandular differentiation in invasive/noninvasive urothelial carcinoma of the urinary bladder.
    Behzatoğlu K
    Ann Diagn Pathol; 2011 Dec; 15(6):422-6. PubMed ID: 21855380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ABO(H) isoantigens in bladder tumors: a new technique of quantitative analysis.
    Srinivas V; Kiruluta HG
    J Urol; 1984 Feb; 131(2):245-8. PubMed ID: 6699953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical demonstration of blood group antigens in neoplastic and normal human urothelium: a comparison with standard red cell adherence.
    Flanigan RC; King CT; Clark TD; Cash JB; Greenfield BJ; Sniecinski IJ; Primus FJ
    J Urol; 1983 Sep; 130(3):499-503. PubMed ID: 6350617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell surface antigen in bilharzial bladder tumours.
    Halim A; Javadpour N; Kasraeian A; Young JD
    Br J Urol; 1986 Oct; 58(5):523-5. PubMed ID: 3096417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and biosynthesis of ABH-related carbohydrate antigens in normal and pathologic human urothelium.
    Orntoft TF
    APMIS Suppl; 1990; 17():1-34. PubMed ID: 1698403
    [No Abstract]   [Full Text] [Related]  

  • 29. The ABO(H) cell surface antigens in carcinoma and benign lesions of the breast.
    Shull JH; Javadpour N; Soares T; Demoss EV
    J Surg Oncol; 1981; 18(2):193-6. PubMed ID: 7300366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative analysis of the A, B and H isoantigens in single transitional carcinoma cells.
    Borgström E; Wahren B
    J Urol; 1985 Jul; 134(1):199-202. PubMed ID: 3892047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revelation of AB cell surface antigens on bladder-washing specimens with the immunofluorescence technique. An approach to automated cytology.
    Devonec M; Fontanière B; Blanc-Brunat N; Muchada E; Dubernard JM
    Eur Urol; 1984; 10(5):323-5. PubMed ID: 6394344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carcinoma in situ of the bladder.
    Hudson MA; Herr HW
    J Urol; 1995 Mar; 153(3 Pt 1):564-72. PubMed ID: 7861485
    [No Abstract]   [Full Text] [Related]  

  • 34. Correlation of urine cytology with ABO(H) antigenicity in transitional cell carcinoma of the bladder.
    Das G; Glashan RW
    J Clin Pathol; 1988 May; 41(5):538-9. PubMed ID: 3384984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Red cell surface antigen and its relationship to survival of patients with transitional cell carcinoma of the bladder.
    Askari A; Colmenares E; Saberi A; Jarman WD
    J Urol; 1981 Feb; 125(2):182-4. PubMed ID: 7206050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic detection and prognosis of patients with transitional cell carcinoma of the urinary bladder.
    Tan LB; Lin LM; Huang CH; Chiang CP; Chien CH; Pan CC
    Urol Int; 1989; 44(5):264-71. PubMed ID: 2800062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epithelial abnormalities of urinary bladder.
    Mostofi FK; Davis CJ
    Prog Clin Biol Res; 1984; 162A():81-93. PubMed ID: 6483921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomere shortening and chromosomal abnormalities in intestinal metaplasia of the urinary bladder.
    Morton MJ; Zhang S; Lopez-Beltran A; MacLennan GT; Eble JN; Montironi R; Sung MT; Tan PH; Zheng S; Zhou H; Cheng L
    Clin Cancer Res; 2007 Oct; 13(20):6232-6. PubMed ID: 17947491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The spectrum of histopathologic findings in vesical diverticulum: implications for pathogenesis and staging.
    Idrees MT; Alexander RE; Kum JB; Cheng L
    Hum Pathol; 2013 Jul; 44(7):1223-32. PubMed ID: 23375647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Significance of isoantigen in the management of the urinary bladder tumor--a basic study of ABO isoantigen in step sections of the entire bladder].
    Ogawa T; Sugimoto M; Hamami G; Kamidono S
    Hinyokika Kiyo; 1989 Jan; 35(1):13-25. PubMed ID: 2729014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.